000 | 01498 a2200445 4500 | ||
---|---|---|---|
005 | 20250518011938.0 | ||
264 | 0 | _c20190305 | |
008 | 201903s 0 0 eng d | ||
022 | _a1879-2472 | ||
024 | 7 |
_a10.1016/j.thromres.2018.11.023 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSpinthakis, Nikolaos | |
245 | 0 | 0 |
_aEffect of P2Y _h[electronic resource] |
260 |
_bThrombosis research _c01 2019 |
||
300 |
_a102-108 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Observational Study | ||
650 | 0 | 4 |
_aAdenosine Monophosphate _xanalogs & derivatives |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAspirin _xtherapeutic use |
650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
650 | 0 | 4 |
_aClopidogrel _xtherapeutic use |
650 | 0 | 4 |
_aCoronary Artery Disease _xcomplications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFibrin Clot Lysis Time |
650 | 0 | 4 |
_aFibrinolysis _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aPurinergic P2Y Receptor Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aThrombosis _xblood |
650 | 0 | 4 |
_aTicagrelor _xtherapeutic use |
700 | 1 | _aFarag, Mohamed | |
700 | 1 | _aGue, Ying X | |
700 | 1 | _aSrinivasan, Manivannan | |
700 | 1 | _aWellsted, David M | |
700 | 1 | _aGorog, Diana A | |
773 | 0 |
_tThrombosis research _gvol. 173 _gp. 102-108 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.thromres.2018.11.023 _zAvailable from publisher's website |
999 |
_c29114624 _d29114624 |